CXCR1 expression predicts benefit from tyrosine kinase inhibitors therapy in patients with metastatic renal cell carcinoma
Urologic Oncology: Seminars and Original Investigations | Jan 25, 2018
Most read this week
Urologic Oncology: Seminars and Original Investigations | Jan 25, 2018